Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1134090 | 0.91 | TSHR (0.50) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL13197654 | 0.89 | TSHR (0.54) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL13367482 | 0.85 | TSHR (0.48) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL20650361 | 0.84 | TSHR (0.65) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL24145271 | 0.84 | KIF11 (0.52) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL13322018 | 0.84 | TSHR (0.71) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL11994079 | 0.84 | TSHR (0.71) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL16682899 | 0.84 | TSHR (0.71) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL19996361 | 0.84 | TSHR (0.71) | TSHRALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL22083898 | 0.83 | ALDH1A1 (0.67) | TSHRALDH1A1MAPTRAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-11584753-B2 | Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) | MERCK PATENT GMBH (DE) | 2023-02-21 | — | — | US | disclosed |
| CN-111233700-B | Diimine palladium complex, ligand thereof, preparation method and application | 中国科学技术大学 | 2021-12-14 | — | — | CN | disclosed |
| EP-3544984-B1 | BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | MERCK PATENT GMBH (DE) | 2020-12-23 | — | — | EP | disclosed |
| CN-111233700-A | Diimine palladium complex, ligand thereof, preparation method and application | 中国科学技术大学 | 2020-06-05 | — | — | CN | disclosed |
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20190315764-A1 | BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | MERCK PATENT GMBH (DE) | 2019-10-17 | — | — | US | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
| WO-2018095888-A1 | BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | MERCK PATENT GMBH (DE) | 2018-05-31 | — | — | WO | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | TSHR 3775/4885ALDH1A1 87/4885MAPT 754/4885 |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | TSHR 4256/4885ALDH1A1 1103/4885MAPT 1486/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | TSHR 3775/4885ALDH1A1 87/4885MAPT 754/4885 |
| US-20190315764-A1 | BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | OCIAD1, OCIAD2, AOC1 | TSHR 4385/4885ALDH1A1 99/4885MAPT 2355/4885 |
| US-11584753-B2 | Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) | OCIAD1, OCIAD2, AOC1 | TSHR 4385/4885ALDH1A1 99/4885MAPT 2355/4885 |
| US-20230140877-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | CRY2, CRY1, GLI1 | TSHR 4136/4885ALDH1A1 105/4885MAPT 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.